journal article·2022-01-12

Photodynamic and Contact Killing Polymeric Fabric Coating for Bacteria and SARS-CoV-2

Taylor Wright, Marli Vlok, Tirosh Shapira, Andrea D. Olmstead, François Jean, Michael O. Wolf

Publisher page

Abstract

The development of low-cost, non-toxic, scalable antimicrobial textiles is needed to address the spread of deadly pathogens. Here, we report a polysiloxane textile coating that possesses two modes of antimicrobial inactivation, passive contact inactivation through amine/imine functionalities and active photodynamic inactivation through the generation of reactive oxygen species (ROS). This material can be coated and cross-linked onto natural and synthetic textiles through a simple soak procedure, followed by UV cure to afford materials exhibiting no aqueous leaching and only minimal leaching in organic solvents. This coating minimally impacts the mechanical properties of the fabric while also imparting hydrophobicity. Passive inactivation of Escherichia coli (E. coli) and methicillin-resistant Staphylococcus aureus (MRSA) is achieved with >98% inactivation after 24 h, with a 23× and 3× inactivation rate increase against E. coli and MRSA, respectively, when green light is used to generate ROS. Up to 90% decrease in the infectivity of SARS-CoV-2 after 2 h of irradiated incubation with the material is demonstrated. These results show that modifying textiles with dual-functional polymers results in robust and highly antimicrobial materials that are expected to find widespread use in combating the spread of deadly pathogens.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Photodynamic Therapy Research Studies · Nanoplatforms for cancer theranostics · Antimicrobial agents and applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver BC V6T 1Z1, Canada

Department of Biochemistry & Molecular Biology, University of British Columbia, 2350 Health Sciences Mall, Vancouver BC V6T 1Z3, Canada

Life Sciences Institute, Department of Microbiology and Immunology, University of British Columbia, Vancouver BC V6T 1Z3, Canada

Funding

Genome British Columbia · Natural Sciences and Engineering Research Council of Canada · Mitacs

References (51)

Show source-provided references
1. 10.1371/journal.pone.010859810.1371/journal.pone.0108598 ↗
2. 10.1016/j.ajic.2010.04.19610.1016/j.ajic.2010.04.196 ↗
3. 10.1177/00333549071220020510.1177/003335490712200205 ↗
4. 10.2147/idr.s17724710.2147/idr.s177247 ↗
5. 10.1016/s2468-2667(20)30164-x10.1016/s2468-2667(20)30164-x ↗
6. 10.1001/jama.2020.2139910.1001/jama.2020.21399 ↗
7. 10.1186/s13756-020-00875-710.1186/s13756-020-00875-7 ↗
8. JHU Center for Systems Science and Engineering. COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). https://coronavirus.jhu.edu/map.html (accessed 13 Apr, 2021).
9. World Health Organization. Mask Use in the Context of COVID-19; WHO, 2020.
10. 10.1017/ice.2020.31310.1017/ice.2020.313 ↗
11. 10.1016/j.jare.2020.03.00510.1016/j.jare.2020.03.005 ↗
12. 10.1016/s2666-5247(20)30003-310.1016/s2666-5247(20)30003-3 ↗
13. 10.1056/nejmc200497310.1056/nejmc2004973 ↗
14. 10.3390/ma906049810.3390/ma9060498 ↗
15. 10.1021/acs.bioconjchem.0c0029710.1021/acs.bioconjchem.0c00297 ↗
16. 10.1002/adhm.20140041810.1002/adhm.201400418 ↗
17. 10.1002/adfm.20130168610.1002/adfm.201301686 ↗
18. 10.1016/s1389-5567(04)00023-110.1016/s1389-5567(04)00023-1 ↗
19. 10.1039/C6RA15545F10.1039/C6RA15545F ↗
20. 10.1021/acsbiomaterials.9b0084910.1021/acsbiomaterials.9b00849 ↗
21. 10.1021/ar300098610.1021/ar3000986 ↗
22. 10.1038/srep3269910.1038/srep32699 ↗
23. 10.1002/adfm.20070079310.1002/adfm.200700793 ↗
24. 10.1111/php.1271610.1111/php.12716 ↗
25. 10.1016/s0006-291x(03)00817-910.1016/s0006-291x(03)00817-9 ↗
26. 10.1021/acsami.9b0962510.1021/acsami.9b09625 ↗
27. 10.1021/acsami.6b0823410.1021/acsami.6b08234 ↗
28. 10.1016/j.micres.2007.08.00110.1016/j.micres.2007.08.001 ↗
29. 10.1021/acsami.8b0913910.1021/acsami.8b09139 ↗
30. 10.1021/acsami.0c1695310.1021/acsami.0c16953 ↗
31. 10.1016/j.dyepig.2017.01.03210.1016/j.dyepig.2017.01.032 ↗
32. 10.1021/acsinfecdis.9b0027910.1021/acsinfecdis.9b00279 ↗
33. 10.1080/1091581039020485410.1080/10915810390204854 ↗
34. 10.1002/lsm.1013810.1002/lsm.10138 ↗
35. 10.1021/acsapm.0c0077810.1021/acsapm.0c00778 ↗
36. 10.1039/c004769d10.1039/c004769d ↗
37. 10.1021/cr010371d10.1021/cr010371d ↗
38. 10.3164/jcbn.17-2410.3164/jcbn.17-24 ↗
39. 10.1021/ja960080010.1021/ja9600800 ↗
40. 10.1021/jacs.6b0155510.1021/jacs.6b01555 ↗
41. 10.1021/acsami.1c0286310.1021/acsami.1c02863 ↗
42. 10.1128/jb.171.4.2188-2194.198910.1128/jb.171.4.2188-2194.1989 ↗
43. 10.3389/fmed.2021.65783710.3389/fmed.2021.657837 ↗
44. Shapira, T.; Monreal, I. A.; Dion, S. P.; Jager, M.; Désilets, A.; Olmstead, A. D.; Vandal, T.; Buchholz, D. W.; Imbiakha, B.; Gao, G.; Chin, A.; Rees, W. D.; Steiner, T.; Nabi, I. R.; Marsault, E.; Sahler, J.; August, A.; Van de Walle, G.; Whittaker, G. R.; Boudreault, P.L.; Aguilar, H. C.; Leduc, R.; Jean, F. A Novel Highly Potent Inhibitor Of TMPRSS2-Like Proteases Blocks SARS-CoV-2 Variants Of Concern and is Broadly Protective Against Infection and Mortality in Mice. 2021, bioRxiv:2021.05.03.442520.10.1101/2021.05.03.442520 ↗
45. 10.1021/acsami.0c1744510.1021/acsami.0c17445 ↗
46. 10.1042/bj2013105810.1042/bj20131058 ↗
47. 10.1073/pnas.90.1.15810.1073/pnas.90.1.158 ↗
48. 10.1111/j.1751-1097.1993.tb04926.x10.1111/j.1751-1097.1993.tb04926.x ↗
49. 10.1016/j.redox.2020.10160110.1016/j.redox.2020.101601 ↗
50. 10.2807/1560-7917.ES.2020.26.1.200210610.2807/1560-7917.ES.2020.26.1.2002106 ↗
51. 10.1126/science.abi527310.1126/science.abi5273 ↗